FinancialsIt takes money to make money. MIR in my opinion has done quite well managing with what they have. Yes we were all waiting for FDA approval on the Covid tests but they have expanded their product line considerably beyond just Covid. They have gone from 4 to 65 employees in a few years so the company is growing. They have very positive results from the Syphillis test kit in both Alberta and Saskatchewan and now are moving ahead with clinical trials in Ontario. Approval for use in humans is a slow moving process especially for a small company. I think time will prove out the fruits of their labour. As investors we all want a return yesterday but we have to be patient and allow it to unfold. If you can't wait then maybe it's time to move on instead of repeatedly complaining about management and abshing the stock. I am a long term sharehoder with a substantial amount of shares and I am only too happy to wait.